[Study on determination of sodium, vanadium and aluminum contents in fuel oil by ICP-AES].

The present paper considers synthetically all kinds of factors affecting excitation spectrum under traditional measurement conditions of fluorescence matter in liquor using plasma atomic emission spectra. The input power, carrier gas flow and assistant gas flow for BEC of Na, V, Al were optimized by testing. The input power, carrier gas flow and assistant gas flow for Na are 950 W, 0.6 L x min(-1) and 1.0 L x min(-1), respectively. The input power, carrier gas flow and assistant gas flow for V are 1 150 W, 0.5 and 1.1 L x min(-1), respectively. The input power, carrier gas flow and assistant gas flow for Al are 1 150 W, 0.6 and 1.0 L x min(-1), respectively. The result shows that the method is sensitive, accurate, linear in a wide range and highly precise. The precision is between 1.7%-2.2%, the linear ranges are between 0-100 mg x L(-1) and recoveries are between 96%-105%.

[MOA spectral analysis of additive element contents in lube oil].

The determination of the additive contents of marine lubrication oil by using atomic emission spectrometry is described. A new measuring method is suggested in accordance with the working principle of MOA atomic emission spectral instrument. The additive element contents, if not within the precision limits of MOA atomic emission spectra, are to be measured by being diluted with a standard oil. Error analysis is conducted and the calibration curve method is used. The testing result indicates that the RSD of Ca, P and Zn is 1.6%, 4.8% and 4.6% respectively, and the error result of oil sample before and after diluting is 4.21%, 6.99% and 5.09% respectively.

[Study on the characteristic parameter of oil spectrometric analysis].

This paper establishes a new mathematics model of fault diagnosis basis of oil spectrometric analysis by means of long time following up the mechanical equipment's lubrication oil. The characteristic parameter of oil spectrometric analysis has been confirmed using a new way that the laboratory experiment study and the mechanical equipment's lubrication oil spectrometric analysis are combined in order to confirm the time of fault and avoid serious fault. It will provide the academic and actual basis for RCM and enhance the dependability. The result of examples proves that the characteristic parameter of oil spectrometric analysis has very high stability and veracity. This method has been proved that it was effective in fault diagnosis basis of oil spectrometric analysis.

[Relationship between MDR1 gene polymorphism and blood concentration of tacrolimus in renal transplant patients].

OBJECTIVE: To investigate the relationship between MDR1 exon 21 and exon 26 polymorphism and whole blood concentration of tacrolimus (FK506) in renal transplant patients. METHODS: Blood samples were collected from 86 renal transplant patients who received FK506 peri-operationally. PCR-RELP was used to determine the MDR1 genotype. The patients were divided into 3 subgroups for every position: GG, GT, and TT in exon 21; and CC, CT, and TT in exon 26. Three, six, and twelve months after the transplantation ELISA was used to measure the whole blood concentration of FK506. The FK506 concentrations standardized by dosage and body weight (FK506 concentration per dose/kg) were compared among the 3 subgroups within the MDR1 exon 21 and exon 26 groups. RESULTS: Of the 86 patients 26 (30.2%), 35 (40.7%), and 25 (29.1%) were carriers of GG, GT, and TT in exon 21, and 26 (30.2%), 35 (40.7%), and 23 (26.8%) were carriers of CC, CT, and TT in exon 26. MDR1 exon 26 C3435T was in significant linkage disequilibrium with MDR1 exon 21 G2677T. Three, six, and twelve months after the transplantation a significant correlation between the whole blood FK506 concentration per dose/day and MDR1 exon 21 and exon 26 genotypes. For exon 21 there were significant differences among the 3 subgroups (all P < 0.01). The ratio for the patients with GG was remarkably lower than that of those with GT and TT, and the ratio with GT was also lower than the patients with TT (P < 0.05). For exon 26, there was also a significant difference among the 3 subgroups (all P < 0.01). The ratio for the patients with CC was remarkably lower than those of the patients with CT and TT, and the ratio of CT was also lower than that of TT (P < 0.05). CONCLUSIONS: The MDR1 gene polymorphism is correlated with the whole blood concentration of FK506. To obtain the similar blood concentration of FK506, the patients with GG and CC should take the drug at a higher dose than those with Ct and TT.

[The relationship between the peripheral blood of CD61, CD63, PAC-1 and the transplant kidney function].

OBJECTIVES: To explore the relationships between the peripheral blood levels of CD61, CD63, PAC-1 and the incidence of acute rejection and tubular necrosis after renal transplantation, and recovery of the graft function. METHODS: The peripheral blood levels of CD61, CD63, and PAC-1 of 86 patients with uremia in different stages before and after transplantations were analyzed by flow cytometry. The patients were divided into three groups: (1) twenty-nine patients with normal grafts function, (2) hirty with acute rejection and (3) twenty-seven with acute tubular necrosis. The patients with acute rejection were randomly divided into treatment group with anticoagulants and cntrol group. RESULTS: The peripheral blood levels of CD61, CD63 and PAC-1 significantly increased (P < 0.05) in the patients with acute rejection, in comparison with those with normal grafts function and those with acute tubular necrosis. The peripheral blood levels of CD61, CD63 and PAC-1 in patients with acute rejection in anticoagulants therapy was lower, recovery time of the grafts function was shorter, one-year survival rates of patients and grafts were higher, as compared with those of controls. CONCLUSIONS: The patients with acute rejection have significantly high peripheral blood levels of CD61, CD63 and PAC-1 before transplantation, however, these values in patients with acute tubular necrosis are not high, this suggesting that acute rejection might relate to platelet activation, while acute tubular necrosis might not relate to it. After anticoagulants therapy in patients with acute rejection, the grafts function might recover faster and their one-year survival rates and grafts might be higher in those with CD61, CD63 and PAC-1 decreasing remarkably.